Analyst Downgrade Signal: AMED from Neutral to Underperform by BofA Securities
Price Target: $145>>102
Report Date: 06-21-2022
Symbol: AMED - Amedisys, Inc.
Sector: Healthcare
Industry: Medical Care Facilities
Analyst Downgrade Signal: AMED from Neutral to Underperform by BofA Securities
Price Target: $145>>102
Amedisys, Inc. (AMED)
3854 American Way Ste A
Baton Rouge, LOUISIANA 70816
Phone: 12252922031
Website: http://www.amedisys.com
CEO: Mr. Paul Kusserow
NASDAQ, Nasdaq Global Select
Amedisys, Inc., together with its subsidiaries, provides healthcare services in the United States. It operates through three segments: Home Health, Hospice, and Personal Care. The Home Health segment offers a range of services in the homes of individuals for the recovery of patients from surgery, chronic disability, or terminal illness, as well as prevents avoidable hospital readmissions through its skilled nurses; rehabilitation therapists specialized in physical, speech, and occupational therapy; and social workers and aides for assisting its patients. The Hospice segment offers services that is designed to provide comfort and support for those who are dealing with a terminal illness, including heart disease, pulmonary disease, Alzheimer's, or cancer. The Personal Care segment provides assistance for patients with the activities of daily living. As of February 18, 2020, the company owned and operated 479 care centers in 38 states and the District of Columbia. Amedisys, Inc. was founded in 1982 and is headquartered in Baton Rouge, Louisiana.